ArticleThe journal of pain2021

A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide Agonist.

Juliet Mwirigi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.